Maintenance Notice (10:30 PM August 23 - 3:30 AM August 24, 2025 UTC): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Product Document Searching Made Easy by 2D Code! | TCI Life Science News August 2025 | [Product Highlights] Puberulic Acid: A Compound with... | Various analytical charts can be searched on each product detail page and Product Document Search (The kinds of analytical charts differ by product)
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 33564-30-6 | Product Number: C3602
Cefoxitin Sodium
×
![]()
×
Purity: >98.0%(T)(HPLC)
Synonyms:
- Sodium (6R,7S)-3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[2-(thiophen-2-yl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
|
|---|---|---|---|---|---|
| 1G |
NT$6,426
|
0 | 0 | Contact Us |
* The above prices include freight cost, customs, and other charges to the destination except for products that need to be shipped by sea or dry ice. For details, please contact
our distributor
in Taiwan to order our product.
* The storage conditions are subject to change without notice.
Supplemental Product Information:
This product has not been tested for potency and is guaranteed for chemical purity.
| Product Number | C3602 |
Purity / Analysis Method 
|
>98.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__1__6H__1__6N__3NaO__7S__2 = 449.43 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature
|
Refrigerated (0-10°C) |
| Condition to Avoid | Heat Sensitive |
| CAS RN | 33564-30-6 |
| Reaxys Registry Number | 4104290 |
| PubChem Substance ID | 468591188 |
| Merck Index (14) | 1936 |
| MDL Number | MFCD00079042 |
Specifications
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 % |
| Specific rotation [a]20/D | +202 to +210 deg(C=1, MeOH) |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 204 °C |
| Specific Rotation | 209° (C=1,MeOH) |
| Maximum Absorption Wavelength | 260 nm (H__2O) |
| Solubility (soluble in) | Methanol |
| Solubility (insoluble in) | Aliphatic hydrocarbons |
GHS
Related Laws:
| RTECS# | XI0330500 |
Transport Information:
| H.S.code* | 2941.90-000 |
Application
Cefoxitin Sodium: A Second Generation Cephem Antibiotic against beta-Lactamase
Cefoxitin sodium and its free acid [C3598] are semi-synthetic antibiotic that are derived from cephamycin C which is produced by Streptomyces lactamdurans. Cefoxitins have bactericidal activity against a wide range of Gram-negative and Gram-positive bacteria including aerobes and anaerobes.1,2) Cefoxitins are second generation cephem antibiotics which act by inhibition bacterial cell wall synthesis. Due to the presence of a 7-α methoxy group in the β-lactam ring, cefoxitins exhibit a high degree of stability in the presence of beta-lactamases.1,3)
References
- 1) Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use
- 2) Bioavailability and pharmacokinetics of cefoxitin sodium (a review)
- 3) AmpC β-Lactamases (a review)
- 4) Cefoxitin, Sodium (A Review on the Properties, Synthesis, Stability, Metabolism, and Methods of Determination of Cefoxitin Sodium)
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.